Literature DB >> 14308789

MALIGNANT MELANOMA: A CLINICAL STUDY OF 427 CASES.

E D MUNDTH, E A GURALNICK, J W RAKER.   

Abstract

Keywords:  ANTINEOPLASTIC AGENTS; LYMPH NODE EXCISION; MELANOMA; MORTALITY; NEOPLASM RADIOTHERAPY; NEOPLASM STATISTICS; NEOPLASM THERAPY; PALLIATIVE TREATMENT; PROGNOSIS; SURGERY, OPERATIVE

Mesh：

Substances：

Year:  1965        PMID： 14308789      PMCID： PMC1476795          DOI： 10.1097/00000658-196507000-00003

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  27 in total

1.  End results in the treatment of malignant melanoma; a later report.

Authors:  G T PACK
Journal:  Surgery       Date:  1959-08       Impact factor: 3.982

2.  Malignant melanoma.

Authors:  S CADE
Journal:  Ann R Coll Surg Engl       Date:  1961-06       Impact factor: 1.891

3.  Malignant melanoma; ten-year results following excision and regional gland resection.

Authors:  W S McCUNE; G S LETTERMAN
Journal:  Ann Surg       Date:  1955-06       Impact factor: 12.969

4.  The role of regional node dissection in the treatment of malignant melanoma.

Authors:  H W SOUTHWICK; D P SLAUGHTER; J F HINKAMP; F E JOHNSON
Journal:  Arch Surg       Date:  1962-07

5.  Malignant melanoma: diagnosis and current treatment.

Authors:  J S STEHLIN; J L SMITH; R L CLARK
Journal:  Surg Clin North Am       Date:  1962-04       Impact factor: 2.741

6.  A clinical study of 250 patients with malignant melanoma.

Authors:  P H CHARALAMBIDIS; W B PATTERSON
Journal:  Surg Gynecol Obstet       Date:  1962-09

7.  Treatment of 126 cases of malignant melanoma: long term results.

Authors:  S L GUMPORT; H W MEYER
Journal:  Ann Surg       Date:  1959-12       Impact factor: 12.969

8.  Malignant melanoma; personal experience with 170 cases.

Authors:  E M DALAND
Journal:  N Engl J Med       Date:  1959-03-05       Impact factor: 91.245

9.  The management of malignant melanoma.

Authors:  H P ROYSTER; L M BAKER
Journal:  Ann Surg       Date:  1957-06       Impact factor: 12.969

10.  End results in the treatment of malignant melanoma; a report of 1190 cases.

Authors:  G T PACK; D M GERBER; I M SCHARNAGEL
Journal:  Ann Surg       Date:  1952-12       Impact factor: 12.969
View more
  13 in total

1.  Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.

Authors:  C M McBride; E V Sugarbaker; R C Hickey
Journal:  Ann Surg       Date:  1975-09       Impact factor: 12.969

2.  A ten-year follow-up on stage II malignant melanoma patients treated postsurgically with Newcastle disease virus oncolysate.

Authors:  W A Cassel; D R Murray
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

3.  Malignant melanoma in Jamaica.

Authors:  A K Butler
Journal:  Postgrad Med J       Date:  1967-07       Impact factor: 2.401

Review 4.  Lymph node dissection for melanoma: where do we stand?

Authors:  Madalyn G Neuwirth; Edmund K Bartlett; Giorgos C Karakousis
Journal:  Melanoma Manag       Date:  2017-03-03

5.  [Regional lymph node metastasis in malignant melanoma].

Authors:  F Weidner; O P Hornstein
Journal:  Arch Dermatol Forsch       Date:  1972

6.  Selective regional lymphadenectomy for melanoma: a mathematical aid to clinical judgment.

Authors:  H C Polk; B S Linn
Journal:  Ann Surg       Date:  1971-09       Impact factor: 12.969

7.  Malignant melanomata of the nasal cavity.

Authors:  D F Harrison
Journal:  Proc R Soc Med       Date:  1968-01

8.  Malignant melanoma.

Authors: 
Journal:  Br Med J       Date:  1967-04-15

9.  Early metastases in regional lymph nodes and prognosis of malignant melanoma. Histological and clinical examinations in 104 lymphadenectomized patients.

Authors:  F Weidner; O P Hornstein; P Hermanek; G Wutz
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

10.  Primary melanoma of skin of the breast region.

Authors:  Y T Lee; F C Sparks; D L Morton
Journal:  Ann Surg       Date:  1977-01       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.